Newsroom

HOUSTON--(BUSINESS WIRE)--The Port Commission of the Port of Houston Authority will hold its Regular Monthly Meeting on Tuesday, May 20, 2025, beginning at 9:15 a.m. in the boardroom of the Port Houston Executive Office Building, located at 111 East Loop North, Houston, TX 77029. It will be conducted as a hybrid meeting and open to the public to attend in person or accessed virtually via WebEx webinar. The agenda and instructions for accessing Port Houston public meetings are available at https...

TORONTO--(BUSINESS WIRE)--Almonty Industries Inc. (“Almonty” or the “Company”) (TSX: AII / ASX: AII / OTCQX: ALMTF / Frankfurt: ALI), a leading global producer of tungsten concentrate, today announced its first quarter 2025 financial results. Financial Summary: Unless otherwise indicated, all figures are expressed in Canadian dollars.   Three Months Ended March 31, CAD$ in millions 2025 2024 Revenue $7.91 $7.82 Income from Mining Operations $0.752 $0.606 Operating Expenses $9.5 $4.3 Loss before...

NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of SelectQuote, Inc. (NYSE: SLQT) resulting from allegations that SelectQuote may have issued materially misleading business information to the investing public. So What: If you purchased SelectQuote securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangem...

LOS ANGELES--(BUSINESS WIRE)--DNUT CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against Krispy Kreme, Inc....

LOS ANGELES--(BUSINESS WIRE)--CAPR Investors Have Opportunity to Join Capricor Therapeutics, Inc. Fraud Investigation with the Schall Law Firm...

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of UroGen Pharma Ltd. (“UroGen” or the “Company”) (NASDAQ: URGN) on behalf of investors concerning the Company’s possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON UROGEN PHARMA LTD. (URGN), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On May 16, 2025, the U.S. Food and Drug Administration (“FDA”) publi...

NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of GoHealth, Inc. (NASDAQ: GOCO) resulting from allegations that GoHealth may have issued materially misleading business information to the investing public. So What: If you purchased GoHealth securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. Th...

LOS ANGELES--(BUSINESS WIRE)--DNUT Investors Have Opportunity to Join Krispy Kreme, Inc. Fraud Investigation with the Schall Law Firm...

WILMINGTON, Delaware--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) annonce ce jour que la Food and Drug Administration (FDA) des États-Unis a approuvé le Zynyz® (rétifanlimab-dlwr), un anticorps monoclonal humanisé ciblant la protéine 1 de mort cellulaire programmée (PD-1), en association avec le carboplatine et le paclitaxel (chimiothérapie à base de platine) pour le traitement de première intention des patients adultes atteints d'un carcinome épidermoïde localement récurrent ou métastatique inopérab...

NEW YORK--(BUSINESS WIRE)--KBRA assigns a preliminary rating of "BBB” with Stable Outlook to surplus notes (“Notes”) to be issued by Clear Blue Specialty Insurance Company (CBSIC) (KBRA Insurance Financial Strength Rating: A-/Stable). As surplus notes, the Notes are deeply subordinated and payments thereon are subject to the prior approval of the Texas Department of Insurance. If any payments are not approved, the payment will be extended until approval is given. Interest will continue to accru...